Rapid RV/LV vs VX1
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your primary need is a rapid, automated assessment of pulmonary embolism (PE) severity from CTPA scans. This tool is ideal for emergency departments and critical care settings where quick, objective measurements of RV/LV ratios are crucial for timely patient triage and guiding treatment decisions for suspected PE cases. It helps standardize the evaluation process and reduce inter-rater variability in urgent scenarios.
View Rapid RV/LV →Choose VX1 if…
Choose VX1 if you are an electrophysiologist seeking real-time AI guidance during atrial fibrillation or atrial tachycardia ablation procedures. This tool is specifically designed to assist in identifying dispersed electrograms, aiming to improve the precision and consistency of ablation targets. It is best suited for EP labs looking to enhance procedural efficacy, reduce inter-operator variability, and potentially standardize outcomes in complex arrhythmia ablations.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | VX1 |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Contact for pricing |
| Deployment | Unknown | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VX1While both tools offer streamlined workflows and rapid results, VX1 provides real-time, AI-guided assistance directly during complex atrial fibrillation ablation procedures. Its simple, color-coded interface and visual/sound cues offer immediate, interactive utility in a live clinical setting, which is a higher degree of integrated usability compared to Rapid RV/LV's post-scan analysis and notification system.
Clinical Value
VX1Both tools are FDA-cleared and offer significant clinical value by improving diagnostic speed and reducing variability. Rapid RV/LV provides rapid assessment of pulmonary embolism severity. However, VX1 standardizes complex AFib ablation procedures, which are highly operator-dependent, and has demonstrated promising long-term patient outcomes in initial studies, including high freedom from AF and atrial arrhythmia.
Pricing & Value
TieBoth Rapid RV/LV and VX1 require contacting the vendor for pricing information, indicating a lack of transparency. While VX1 mentions a Software-as-a-Service (SaaS) model based on patient volume, neither tool provides specific pricing details. Therefore, a direct comparison of their pricing or overall value proposition is not possible.
Enterprise Readiness
Rapid RV/LVRapid RV/LV explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with flexible on-premises or hybrid deployment options and EMR integration. VX1 lacks explicit statements regarding HIPAA compliance and BAA in the provided information, making Rapid RV/LV appear more robustly prepared for enterprise adoption from a compliance and infrastructure standpoint.
Innovation
VX1Both tools leverage AI for critical clinical challenges. However, VX1 is noted as the 'first FDA clearance for an AI based tool in interventional cardiac electrophysiology,' providing real-time, AI-guided decision support during a complex, invasive ablation procedure. This direct, real-time intervention during a live procedure represents a higher degree of innovation compared to Rapid RV/LV's post-scan analysis.
Support & Docs
Rapid RV/LVRapidAI (Tool A) offers comprehensive 24/7 customer support via email and phone, including multiple international numbers and language support, along with professional education and implementation resources. While Volta Medical (Tool B) provides a user manual and brochure, it does not detail a comparable level of accessible and extensive support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | VX1 |
|---|---|---|
| Name | Rapid RV/LV | VX1 |
| Company | RapidAI (formerly iSchemaView) | Volta Medical |
| Description | FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Key Features | AI-powered analysis of CTPA images, Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio, Annotated images showing ventricular measurements, Rapid results (within minutes of scan), Reduces inter-rater variability, Integration with Rapid PE solution, Triage and notification capabilities (as part of the broader Rapid platform) | AI-guided real-time identification of dispersed electrograms (EGMs), Assists cardiologists during AFib and atrial tachycardia ablation procedures, Analyzes 3D anatomical and electrical maps of human atria, Compatible with most EP recording, 3D navigation systems, and mapping catheters, Designed to reduce inter-operator variability and standardize outcomes, Provides cycle length estimation from electrograms, Booster mode for increased sensitivity during AT or slow AF |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and VX1.